BloodThinnerHelp.com reports today with an update regarding the Xarelto litigation. Recently, a lawsuit that was originally filed in the Eastern District of New York was consolidated into the federal multidistrict litigation in the Eastern District of Louisiana in New Orleans. This particular lawsuit was filed in New York by a Texas woman who alleges that the manufacturers of Xarelto’s failure to warn patients and doctors of the drug’s serious risks and their failure to perform sufficient safety testing on the drug lead to her serious injuries. The complaint is filed under federal court docket number 1:14-CV-04524 and can be downloaded and read here.
Details of the Texas Woman’s Lawsuit:
In this particular Xarelto lawsuit, the plaintiff was initially prescribed Xarelto by her primary care doctor to treat her atrial fibrillation, a heart condition that can cause blood clots and stroke. The plaintiff took the blood thinner regularly for five months when she suffered from a life threatening internal bleeding incident. This incident left her with serious injuries that are not specified in the complaint. The complaint states that her injuries will require long term future care.
Xarelto Lawsuit Information:
Xarelto was initially approved by the Food and Drug Administration, FDA, in 2011 to treat atrial fibrillation, deep vein thrombosis, to be used in patients who had recently undergone a hip or knee replacement surgery, and to generally treat blood clots. The blood thinner was marketed as a more convenient alternative to other blood thinners on the market because it did not require regular blood monitoring or a restrictive diet. However, as more and more prescriptions were written for Xarelto, reports of Xarelto users experiencing adverse events began to be filed with the FDA. Soon after, the FDA began to release reports regarding the dangers of Xarelto. Xarelto currently has two black box warnings attached to it by the FDA. The black box warning is the strictest warning the FDA can attach to a drug short of recalling it. It means that there is a reasonable risk of harm associated with the drug.
Xarelto Lawsuits Point to Manufacturers Negligence:
In December 2014, the number of Xarelto lawsuits had grown so much that a motion was made to consolidate them into a MDL. The Xarelto MDL is based out of the Eastern Distrcit of Louisiana and is presided over by Judge Eldon Fallon. There are currently more than 1,200 lawsuits filed in the MDL and the number is continually rising.
For any questions regarding this press release or the pending Xarelto litigation, please contact Marc Goldich at (866) 425-8902.
###
Contact BloodThinnerHelp.com:
Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.
